(Press-News.org) UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.
The team found that extremely low doses of the drug lenalidomide can stimulate the body's immune-cell protein factories, which decrease production during aging, and rebalance the levels of several key cytokines – immune proteins that either attack viruses and bacteria or cause inflammation that leads to an overall decline in health.
The initial study, which was designed to define the dose range of such a therapy in a group of 13 patients, could lead to a daily pill to boost immunity in the elderly, the researchers said. Data will appear in the January issue of the journal Clinical Immunology, and can be found online at www.elsevier.com/locate/yclim.
The identification of a drug to reverse the immunological decline in aging, known as immunosenescence, is the culmination of years of research by Edward J. Goetzl, MD, at UCSF and the National Institute on Aging, into how cytokine levels change as people age, how that varies by gender, and which changes dictate whether someone will be healthy into their 90s or begin a downward cycle of decline starting in middle age.
"No one's really talking about longevity and lifespan now, but about 'health span,'" said Goetzl, director of UCSF Allergy and Immunology Research, which focuses on developing new diagnostics and treatments for allergic and immunological diseases.
"If, at age 50, your cytokine levels are the same as they were at 25, you'll probably stay healthy as you age," he said. "But if they're heading downhill, we need to do something about it. If you could take a low-dosage pill with no side effects, wouldn't you do it?"
In 2009, Goetzl had studied a group of 50 elderly adults through the National Institute on Aging, examining their levels of key cytokines – Interleukin (IL)-2, IFN-gamma and IL-17 – and discovered that truly healthy 70-80 year old women had the same levels of those as did healthy 20 year olds.
However, elderly men and frail women who showed increased levels of inflammatory diseases and weakened defenses against infections tended to have lower levels of the first two cytokines, which are protective, and higher levels of IL-17, which is linked to inflammation. That imbalance, the researchers found, began in late middle age.
They then set out to find a drug that could raise IL-2 and IFN-gamma and either have no effect on IL-17 or lower it.
"We now had a profile – in humans – that we could take to test tubes to say, 'Does this drug have a desirable effect?'" Goetzl said. "Our job was to find a therapy that not only works, but does so at a dose range with no side effects."
The team focused on three classes of drugs, among them the one that includes lenalidomide – a derivative of thalidomide – which is undergoing a renaissance, Goetzl said.
First introduced in the late 1950s as a sedative, thalidomide was never approved in the United States, but was withdrawn from the world market in 1961 after causing severe birth defects in infants whose mothers took the drug to reduce nausea during pregnancy.
In recent years, however, lenalidomide has been found to be an effective co-therapy for some cancers, particularly multiple myeloma and kidney tumors, as well as leprosy, at doses of 5 mg to 20 mg per day. Those cancers are tied to a drop in IL-2, the main cytokine that Goetzl's team had linked to declines in aging immune systems.
In this study, the team tested the drug in healthy seniors, each of whom were matched in race, gender and national origin to a healthy young adult participant. They found that extremely low levels of lenalidomide – 0.1 μM – optimally stimulated IL-2 production in the young people (21-40 years) roughly sevenfold, but stimulated IL-2 production in patients over age 65 by 120-fold, restoring them to youthful levels for up to five days. At that dosage, the drug also increased IFN-gamma up to six fold in the elderly patients, without suppressing IL-17 generation.
The researchers also found that lenalidomide had many other beneficial effects on the elderly participants' T cells, including better migration throughout the body, more efficient patrolling activity and longer survival after defending the body against an infection.
The team plans to begin larger-scale clinical trials in 2011 to test the drug's effectiveness and hopes for broader availability within a few years.
INFORMATION:
The research was supported by a grant from the Kenneth Rainin Foundation and by the Intramural Research Program of the National Institute on Aging. The authors declare no conflicts of interest.
The first author on the paper is Mei-Chuan Huang, who, along with Goetzl and co-author Janice B. Schwartz, is from the UCSF departments of Microbiology-Immunology and of Medicine. Co-authors are Nigel Greig, Weiming Luo, David Tweedie, Dan Longo, Luigi Ferrucci and William B. Ershler, all from the National Institute on Aging, of the National Institutes of Health, in Baltimore.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
UCSF 'fountain of youth' pill could restore aging immune system
2010-12-14
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Early years' initiatives, such as Sure Start, are failing the poor, eight-year study shows
2010-12-14
Early years initiatives for pre-school children are not delivering improvements in language and numeracy development, according to leading education experts.
Experts, conducting one of the largest surveys to date of the development of 117,000 children starting primary school in England over eight years, found that despite a raft of early years' initiatives, such as 'Sure Start', basic levels of development in early reading, vocabulary and maths have remained largely unchanged.
Researchers from the Centre for Evaluation and Monitoring (CEM) at Durham University who ...
U-M researchers discover way to block neurodegeneration in an adult form of Fragile X syndrome
2010-12-14
Ann Arbor, Mich.— Expression of a toxic RNA that leads to Fragile X Tremor Ataxia Syndrome is modifiable by genetic or pharmacologic means, according to new research from U-M Medical School scientists.
In the study published online today in the journal Public Library Of Science Genetics, U-M's Peter K. Todd, M.D., Ph.D., led a team of researchers who examined the expression of a toxic messenger RNA (mRNA) seen in the brains of those afflicted with the syndrome.
Fragile X Tremor Ataxia Syndrome (FXTAS) is usually found in older adults, who often have grandchildren afflicted ...
Mexican immigrants' health declines as they assimilate to America
2010-12-14
Mexican-Americans who are most integrated into the culture -- including those born in the United States, and not recent immigrants -- appear less healthy and more likely to require resources to manage their health conditions than more recent, less-integrated migrants, according to a new study from Rice University, Duke University and the University of Colorado Denver.
In particular, the research reveals that this pattern of declining health among immigrants who are in the U.S. the longest holds more strongly for men than women. Conversely, the research indicates that, ...
Study: Personal contacts at work help people better understand organ donation
2010-12-14
WEST LAFAYETTE, Ind. - Face-to-face workplace interactions may be the best way to educate and encourage people to consider becoming organ donors, according to new research from Purdue University.
"Workplaces are a key location for people to learn about health and wellness issues, but how information is distributed in this setting can make a difference for sensitive health topics such as organ donation," said Susan E. Morgan, a professor of communication. "There is an incredible amount of misinformation and medical mistrust surrounding the organ donation process, which ...
Strength training for seniors provides cognitive function, economic benefits: VCH-UBC study
2010-12-14
A one-year follow-up study on seniors who participated in a strength training exercise program shows sustained cognitive benefits as well as savings for the healthcare system. The research, conducted at the Centre for Hip Health and Mobility at Vancouver Coastal Health and the University of British Columbia, is published today in the Archives of Internal Medicine.
The study is the first to examine whether both cognitive and economic benefits are sustained after formal cessation of a tailored exercise program. It builds on the Brain Power Study, published in the January ...
2009 H1N1 vaccine safe and induces robust immune response in people with asthma
2010-12-14
Results from a government-sponsored clinical trial of inactivated 2009 H1N1 influenza vaccine in people with asthma indicate that a single dose of vaccine was safe and induced a strong immune response predictive of protection. The findings also suggest that individuals over the age of 60 who have severe asthma may require a larger dose of vaccine.
The study was cosponsored by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Heart, Lung, and Blood Institute (NHLBI), two components of the National Institutes of Health, and appears online ...
Scientist shows link between diet and onset of mental illness
2010-12-14
WEST LAFAYETTE, Ind. - Changes in diet have been linked to a reduction of abnormal behaviors in mentally ill people or animals, but a Purdue University study shows that diet might also trigger the onset of mental illness in the first place.
Joseph Garner, an associate professor of animal sciences, fed mice a diet high in sugar and tryptophan that was expected to reduce abnormal hair-pulling. Instead, mice that were already ill worsened their hair-pulling behaviors or started a new self-injurious scratching behavior, and the seemingly healthy mice developed the same abnormal ...
Expert: Seven-year moratorium on Gulf oil drilling an unwise decision
2010-12-14
CHAMPAIGN, Ill. – The Obama administration's decision to maintain a ban on oil drilling in the eastern Gulf of Mexico and off the Atlantic and Pacific coasts is a mistake, according to a University of Illinois expert who wrote a six-volume book series on marine pollution.
"It's a ridiculous decision on the part of the Interior Department," said John W. Kindt, a professor of business and legal policy at Illinois. "The previous 180-day moratorium really hurt a lot of businesses. Well, a seven-year ban is going to sting even more."
Kindt says giving the oil companies a ...
UCLA bioengineers discover how particles self-assemble in flowing fluids
2010-12-14
From atomic crystals to spiral galaxies, self-assembly is ubiquitous in nature. In biological processes, self-assembly at the molecular level is particularly prevalent.
Phospholipids, for example, will self-assemble into a bilayer to form a cell membrane, and actin, a protein that supports and shapes a cell's structure, continuously self-assembles and disassembles during cell movement.
Bioengineers at the UCLA Henry Samueli School of Engineering and Applied Science have been exploring a unique phenomenon whereby randomly dispersed microparticles self-assemble into ...
Satellite data provide a new way to monitor groundwater in agricultural regions
2010-12-14
When you dive into that salad full of lettuce grown in the American West, there's a good chance you are enjoying the product of irrigation from an underground water source. These hidden groundwater systems are precious resources that need careful management, but regulatory groups have a hard time monitoring them, owing to a lack of accurate data.
Now, scientists at Stanford have found a way to cheaply and effectively monitor aquifer levels in agricultural regions using data from satellites that are already in orbit mapping the shape of Earth's surface with millimeter ...